Login / Signup

Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.

M GooderhamB E ElewskiD M PariserHoward SofenA M MendelsohnS J RozzoQ Li
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Keyphrases
  • risk factors
  • atopic dermatitis
  • newly diagnosed